Key facts
- Matthew Kawa, owner of Paradigm Peptides, was sentenced to over five years in prison.
- Jennifer Stechkober, Kawa's sister, received a 16-month sentence.
- Paradigm Peptides sold unapproved medicines to thousands of consumers globally.
- The company's products included supplements mixed with testosterone.
- Paradigm Peptides falsely claimed its products were tested.
- The company falsely claimed its products were U.S.-made.
- The products were imported and unanalyzed.
- Matthew Kawa was the owner of Paradigm Peptides.
Matthew Kawa, the owner of Paradigm Peptides, has been sentenced to more than five years in federal prison for selling unapproved medicines. The company supplied thousands of consumers globally with products that were falsely advertised as tested and U.S.-made, but were in fact imported and unanalyzed. Among the substances distributed were supplements mixed with testosterone. Kawa's sister, Jennifer Stechkober, also received a prison sentence of 16 months for her role in the scheme. The sentencing concludes a case where the company engaged in deceptive practices regarding the safety and origin of its pharmaceutical products.